You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Establishing a New Orthotopic Composite Hemiface/Calvaria Transplantation Model in Rabbits

Nie, Chunlei M.D.; Yang, Daping M.D.; Li, Ning M.D.; Liu, Guofeng M.D.; Guo, Tiefang M.D.

Plastic & Reconstructive Surgery:
doi: 10.1097/PRS.0b013e31817d6295
Experimental: Original Articles
Abstract

Background: Composite tissue allograft transplantation provides a better reconstructive option for patients who suffer from extensive craniomaxillofacial deformities. However, there is a lack of sufficient experimental data including anatomical and immunologic aspects in larger animals. The purpose of this study was to develop a new orthotopic composite hemiface/calvaria transplantation model in rabbits with which to estimate the feasibility of composite tissue allografts.

Methods: A total of 36 rabbits were studied. The anatomical features were explored in six rabbits. Group I (n = 6) represented the autograft group. In the allograft control group (group II, n = 12) and the treatment group (group III, n = 12), orthotopic composite hemiface/calvaria allotransplantations were performed from Dutch to Japanese White rabbits. Recipients in the treatment group received low-dose cyclosporine A/prednisone combination therapy. Evaluation methods included clinical inspection, histologic analysis, immunohistochemistry, and radiography.

Results: The animals in the autograft group survived indefinitely. Four of six nontreated allografts were rejected within 7 to 10 days. In the treatment group, five of six recipients showed no signs of rejection up to the endpoint of the study. Only one recipient died as a result of anorexia, on day 18. The histologic outcomes were well correlated with clinical inspection. Bone biopsy specimens at posttransplant days 7 and 120 revealed viable bone. Radiologic grade at day 120 showed no significant difference between the autograft (10.67 ± 1.03) and treatment groups (9.2 ± 1.30).

Conclusions: Low-dose cyclosporine A/prednisone combination therapy does not influence bone viability and healing. A new orthotopic hemiface/calvaria allotransplantation model was established successfully that allows further studies on reconstruction of extensive craniomaxillofacial defects.

Author Information

Harbin, People’s Republic of China

From the Department of Plastic Surgery, the Second Hospital of Harbin Medical University.

Received for publication October 24, 2007; accepted January 7, 2008.

Disclosure: The authors have no conflicts of interest to disclose.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text; simply type the URL address into any web browser to access this content. Clickable links to the material are provided in the HTML text and PDF of this article on the Journal’s Web site (www.PRSJournal.com).

Daping Yang, M.D., Division of Plastic Surgery, Second Hospital of Harbin Medical University, Harbin, People’s Republic of China 150086, dapingyang@hotmail.com

©2008American Society of Plastic Surgeons